Top References from www.sec.gov
| Score | Article | Date | Citations |
|---|---|---|---|
| 6.8 |
Historical Summary of Chairmen and Commissioners of the Securities and Exchange Commissionhttps://www.sec.gov/about/sec-commissioners/sec-historical-summary-chairmen-commissioners |
N/A | 2 |
| 6.8 |
SEC Commissionershttps://www.sec.gov/about/sec-commissioners |
N/A | 2 |
| 6.8 |
Inline XBRL Viewerhttps://www.sec.gov/ix?doc=/Archives/edgar/data/0001046311/000104631125000007/chh-20241231.htm |
N/A | 2 |
| 6.8 |
Warner Bros. Discovery Board Of Directors Unanimously Recommends Shareholders Reject Amended Paramount Tender Offerhttps://www.sec.gov/Archives/edgar/data/1437107/000119312526005429/d75660d425.htm |
N/A | 2 |
| 6.8 |
Form S-1 – Registration Statement Under the Securities Act of 1933 – Bridgetown Holdings Limitedhttps://www.sec.gov/Archives/edgar/data/1815086/000121390020028092/fs12020_bridgetownholdings.htm |
N/A | 2 |
| 6.8 |
Schering AG Form 20-F (2005)https://www.sec.gov/Archives/edgar/data/1124139/000116854806000019/annrept20f2005.htm |
N/A | 2 |
| 6.8 |
Prospectus Filed Pursuant to Rule 424(B)(4) – Registration No. 333-251860 – $260,000,000 Bridgetown 2 Holdings Limited 26,000,000 Class A Ordinary Shareshttps://www.sec.gov/Archives/edgar/data/1831236/000121390021004685/f424b40121_bridgetown2.htm |
N/A | 2 |
| 3.4 |
Press releasehttps://www.sec.gov/Archives/edgar/data/789073/000119312511146638/dex991.htm |
N/A | 1 |
| 3.4 |
2025 Annual Report (Form 20-F)https://www.sec.gov/Archives/edgar/data/1345099/000134509925000067/meso-20250630.htm |
N/A | 1 |
| 3.4 |
gme-20231028https://www.sec.gov/Archives/edgar/data/1326380/000132638023000063/gme-20231028.htm |
N/A | 1 |
| 3.4 |
Anthony Viggiano, CPAhttps://www.sec.gov/enforcement-litigation/litigation-releases/lr-26417 |
N/A | 1 |
| 3.4 |
Press Release: Former UnitedHealth Group CEO/Chairman Settles Stock Options Backdating Case for $468 Million; 2007-255; Dec. 6, 2007http://www.sec.gov/news/press/2007/2007-255.htm |
N/A | 1 |
| 3.4 |
Release No. 37419https://www.sec.gov/files/litigation/admin/3437419.txt |
N/A | 1 |
| 3.4 |
SEC FORM 4https://www.sec.gov/Archives/edgar/data/1321655/000132165525000113/xslF345X05/wk-form4_1755906867.xml |
N/A | 1 |
| 3.4 |
Meetings & Events (Sunshine Act notices)https://www.sec.gov/newsroom/meetings-events |
N/A | 1 |
| 3.4 |
FY 2025 Annual Report (Form 10-K)https://www.sec.gov/ix?doc=/Archives/edgar/data/857005/000119312525291326/ptc-20250930.htm |
N/A | 1 |
| 3.4 |
Press Releasehttps://www.sec.gov/Archives/edgar/data/789073/000119312510276115/dex991.htm |
N/A | 1 |
| 3.4 |
U.S. SEC Schedule 14A: Onyx Pharmaceuticals, Inc.https://www.sec.gov/Archives/edgar/data/1012140/000104746913004146/a2214301zdef14a.htm |
N/A | 1 |
| 3.4 |
Investigation of Failure of the SEC to Uncover Bernard Madoff's Ponzi Schemehttps://www.sec.gov/about/reports-publications/newsstudies2009oig-509pdf |
N/A | 1 |
| 3.4 |
Bridgetown 3 Holdings Limitedhttps://www.sec.gov/Archives/edgar/data/1844028/000121390021012944/filename1.htm |
N/A | 1 |
| 3.4 |
Mark K. Schonfeld, Director of New York Regional Office, to Leave SEChttps://www.sec.gov/news/press/2008/2008-194.htm |
N/A | 1 |
| 3.4 |
Comcast Corporation 2025 Annual Report (Form 10-K)https://www.sec.gov/ix?doc=/Archives/edgar/data/1166691/000162828026004994/cmcsa-20251231.htm |
N/A | 1 |
| 3.4 |
MEDICAL PROPERTIES TRUST, INC. REPORTS RESULTS FOR THE YEAR AND FOURTH QUARTER ENDED DECEMBER 31, 2005https://www.sec.gov/Archives/edgar/data/1287865/000095014406000557/g99317exv99w1.htm |
N/A | 1 |
| 3.4 |
MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTShttps://www.sec.gov/Archives/edgar/data/1287865/000095014406009856/g03898exv99w1.htm |
N/A | 1 |
| 3.4 |
SEC FORM 13-F Information Tablehttps://www.sec.gov/Archives/edgar/data/1067983/000095012325008343/xslForm13F_X02/43977.xml |
N/A | 1 |
| 3.4 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013https://www.sec.gov/Archives/edgar/data/1287865/000119312514080657/d630681d10k.htm |
N/A | 1 |
| 3.4 |
PROSPECTUS SUPPLEMENT NEPTUNE WELLNESS SOLUTIONS INC., US$ 12,650,000, 4,773,584 Common Shares (Form Type: SUPPL, Filing Date: 07/15/2020)https://www.sec.gov/Archives/edgar/data/1401395/000119312520193214/d50386dsuppl.htm |
N/A | 1 |
| 3.4 |
PROSPECTUS SUPPLEMENT NEPTUNE WELLNESS SOLUTIONS INC., US$ 55,000,000, 27,500,000 Common Shares (Form Type: SUPPL, Filing Date: 02/19/2021)https://www.sec.gov/Archives/edgar/data/1401395/000119312521048611/d122850dsuppl.htm |
N/A | 1 |
| 3.4 |
NEPTUNE WELLNESS SOLUTIONS INC. Form 8K (Form Type: 8K, Filing Date: 03/06/2023)https://www.sec.gov/ix?doc=/Archives/edgar/data/0001401395/000143774924006862/nept20240306_8k.htm |
N/A | 1 |
| 3.4 |
SEC Complaint excerpt referencing ArthroCare 2008 Form 10-K (restated)https://www.sec.gov/files/litigation/complaints/2012/comp22315.pdf |
N/A | 1 |
| 3.4 |
Form Type: F‑1 (Registration Statement)https://www.sec.gov/Archives/edgar/data/1356570/000114554906001063/x92712fv1za.htm?utm_source=chatgpt.com#126 |
N/A | 1 |
| 3.4 |
SoFi Technologies, Inc. Form 8-Khttps://www.sec.gov/ix?doc=/Archives/edgar/data/0001818874/000181887426000008/sofi-20260130.htm |
N/A | 1 |
| 3.4 |
RCI Statement Regarding New York Attorney General’s Chargeshttps://www.sec.gov/Archives/edgar/data/935419/000162828025042175/rick-xstatementregardingny.htm |
N/A | 1 |
| 3.4 |
Federal-Mogul U.S. Asbestos Personal Injury Trust Agreemeenthttps://www.sec.gov/Archives/edgar/data/1419581/000095013708000055/c21982exv4w1.htm |
N/A | 1 |
| 3.4 |
NEPTUNE WELLNESS SOLUTIONS INC. Form 8K (Form Type: 8K, Filing Date: 04/12/2024)https://www.sec.gov/ix?doc=/Archives/edgar/data/0001401395/000143774924011920/nept20240412_8k.htm |
N/A | 1 |
| 3.4 |
American Exceptionalism Acquisition Corp. A Announces Pricing of Upsized $300,000,000 Initial Public Offeringhttps://www.sec.gov/Archives/edgar/data/2079173/000119312525223444/d82578dex991.htm |
N/A | 1 |
| 3.4 |
Form 10-Khttps://www.sec.gov/Archives/edgar/data/1026214/000119312513084154/d477952d10k.htm |
N/A | 1 |
| 3.4 |
Form 10-K for FY 2025https://www.sec.gov/ix?doc=/Archives/edgar/data/0000866374/000086637425000027/flex-20250331.htm |
N/A | 1 |
| 3.4 |
Exodus Movement, Inchttps://www.sec.gov/Archives/edgar/data/1821534/000114036121012255/nt10013846x18_253g2.htm |
N/A | 1 |
| 3.4 |
Lam Research Corporation FY 2025 Annual Report (Form 10-K)https://www.sec.gov/ix?doc=/Archives/edgar/data/707549/000070754925000075/lrcx-20250629.htm |
N/A | 1 |
| 3.4 |
thry-20230630https://www.sec.gov/Archives/edgar/data/1556739/000155673923000023/thry-20230630.htm?utm_source=chatgpt.com |
N/A | 1 |
| 3.4 |
Amit Dagar and Atul Bhiwapurkarhttps://www.sec.gov/enforcement-litigation/litigation-releases/lr-26210 |
N/A | 1 |
| 3.4 |
Statement on Judge's Ruling on Sanctions for Fabrice Tourrehttps://www.sec.gov/newsroom/speeches-statements/ceresney-statement-3-12-14 |
N/A | 1 |
| 3.4 |
BioTelemetry, Inc. Form 10-K (FY 2014)https://www.sec.gov/Archives/edgar/data/1574774/000104746915001062/a2223115z10-k.htm |
N/A | 1 |
| 3.4 |
SEC Charges Goldman Sachs With Fraud in Structuring and Marketing of CDO Tied to Subprime Mortgageshttps://www.sec.gov/news/press/2010/2010-59.htm |
N/A | 1 |
| 3.4 |
Division of Enforcementhttps://www.sec.gov/divisions-offices/division-enforcement |
N/A | 1 |
| 3.4 |
Tapestry, Inc. FY25 Annual Report Form 10-Khttps://www.sec.gov/ix?doc=/Archives/edgar/data/1116132/000111613225000019/tpr-20250628.htm |
N/A | 1 |
| 3.4 |
Form 10-Khttps://www.sec.gov/Archives/edgar/data/1005010/000119312506062822/d10k.htm |
N/A | 1 |
| 3.4 |
SEC Expands Sweeping Investigation of Market Manipulationhttps://www.sec.gov/news/press/2008/2008-214.htm |
N/A | 1 |
| 3.4 |
Salesforce Schedule 14https://www.sec.gov/Archives/edgar/data/1108524/000119312524129470/d26900dpre14a.htm |
N/A | 1 |